Literature DB >> 22086851

GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells.

Simon Joost1, Luciana L Almada, Verena Rohnalter, Philipp S Holz, Anne M Vrabel, Maite G Fernandez-Barrena, Robert R McWilliams, Michael Krause, Martin E Fernandez-Zapico, Matthias Lauth.   

Abstract

The Hedgehog (HH) pathway has been identified as an important deregulated signal transduction pathway in pancreatic ductal adenocarcinoma (PDAC), a cancer type characterized by a highly metastatic phenotype. In PDAC, the canonical HH pathway activity is restricted to the stromal compartment while HH signaling in the tumor cells is reduced as a consequence of constitutive KRAS activation. Here, we report that in the tumor compartment of PDAC the HH pathway effector transcription factor GLI1 regulates epithelial differentiation. RNAi-mediated knockdown of GLI1 abolished characteristics of epithelial differentiation, increased cell motility, and synergized with TGFβ to induce an epithelial-to-mesenchymal transition (EMT). Notably, EMT conversion in PDAC cells occurred in the absence of induction of SNAIL or SLUG, two canonical inducers of EMT in many other settings. Further mechanistic analysis revealed that GLI1 directly regulated the transcription of E-cadherin, a key determinant of epithelial tissue organization. Collectively, our findings identify GLI1 as an important positive regulator of epithelial differentiation, and they offer an explanation for how decreased levels of GLI1 are likely to contribute to the highly metastatic phenotype of PDAC. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086851      PMCID: PMC3251693          DOI: 10.1158/0008-5472.CAN-10-4621

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.

Authors:  Matthias Lauth; Asa Bergström; Takashi Shimokawa; Ulrica Tostar; Qianren Jin; Volker Fendrich; Carmen Guerra; Mariano Barbacid; Rune Toftgård
Journal:  Nat Struct Mol Biol       Date:  2010-05-30       Impact factor: 15.369

3.  GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.

Authors:  S Inaguma; K Kasai; H Ikeda
Journal:  Oncogene       Date:  2010-10-25       Impact factor: 9.867

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 6.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

7.  Hedgehog signaling regulates E-cadherin expression for the maintenance of the actin cytoskeleton and tight junctions.

Authors:  Chang Xiao; Sally A Ogle; Michael A Schumacher; Neal Schilling; Robert A Tokhunts; Melissa A Orr-Asman; Marian L Miller; David J Robbins; Frederic Hollande; Yana Zavros
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-16       Impact factor: 4.052

8.  Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.

Authors:  Yan Song; M Kay Washington; Howard C Crawford
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

9.  GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.

Authors:  Olivier Nolan-Stevaux; Janet Lau; Morgan L Truitt; Gerald C Chu; Matthias Hebrok; Martin E Fernández-Zapico; Douglas Hanahan
Journal:  Genes Dev       Date:  2009-01-01       Impact factor: 11.361

Review 10.  Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma.

Authors:  Carla E Cano; Yoshiharu Motoo; Juan L Iovanna
Journal:  ScientificWorldJournal       Date:  2010-10-01
View more
  35 in total

1.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

Authors:  Lindsay J Talbot; Syamal D Bhattacharya; Paul C Kuo
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  Gli1 protein regulates the S-phase checkpoint in tumor cells via Bid protein, and its inhibition sensitizes to DNA topoisomerase 1 inhibitors.

Authors:  Kaushlendra Tripathi; Chinnadurai Mani; Reagan Barnett; Sriram Nalluri; Lavanya Bachaboina; Rodney P Rocconi; Mohammed Athar; Laurie B Owen; Komaraiah Palle
Journal:  J Biol Chem       Date:  2014-09-24       Impact factor: 5.157

Review 3.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

4.  The Role of EMT in Pancreatic Cancer Progression.

Authors:  Qiong Wu; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Pancreat Disord Ther       Date:  2012-09-29

Review 5.  The Hedgehog pathway: role in cell differentiation, polarity and proliferation.

Authors:  Yanfei Jia; Yunshan Wang; Jingwu Xie
Journal:  Arch Toxicol       Date:  2015-01-06       Impact factor: 5.153

Review 6.  WNT signaling in glioblastoma and therapeutic opportunities.

Authors:  Yeri Lee; Jin-Ku Lee; Sun Hee Ahn; Jeongwu Lee; Do-Hyun Nam
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

Review 7.  Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition.

Authors:  Rik Derynck; Baby Periyanayaki Muthusamy; Koy Y Saeteurn
Journal:  Curr Opin Cell Biol       Date:  2014-09-18       Impact factor: 8.382

8.  Inactivation of the transcription factor GLI1 accelerates pancreatic cancer progression.

Authors:  Lisa D Mills; Lizhi Zhang; Ronald Marler; Phyllis Svingen; Maite G Fernandez-Barrena; Maneesh Dave; William Bamlet; Robert R McWilliams; Gloria M Petersen; William Faubion; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2014-04-15       Impact factor: 5.157

9.  The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner.

Authors:  Monica D Nye; Luciana L Almada; Maite G Fernandez-Barrena; David L Marks; Sherine F Elsawa; Anne Vrabel; Ezequiel J Tolosa; Volker Ellenrieder; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

Review 10.  Emerging role of mucins in epithelial to mesenchymal transition.

Authors:  Moorthy P Ponnusamy; Parthasarathy Seshacharyulu; Imayavaramban Lakshmanan; Arokia P Vaz; Seema Chugh; Surinder K Batra
Journal:  Curr Cancer Drug Targets       Date:  2013-11       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.